Search Results - "Nishioka, Chinatsu"

  • Showing 1 - 1 results of 1
Refine Results
  1. 1

    Comparison of outcomes of second-line durvalumab plus tremelimumab versus lenvatinib following first-line atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma.

    Authors: Nishioka, Chinatsu Tahata, Yuki Maesaka, Kazuki et al.

    Source: PLoS ONE. 5/7/2026, Vol. 21 Issue 5, p1-14. 14p.

    HTML Full Text PDF Full Text
    Save to List

Search Tools: